|
Sign In to gain access to subscriptions and/or personal tools.
|
Evaluation of Carcinogenic Responses in the Eker Rat following Short-Term Exposure to Selected Nephrotoxins and Carcinogens
Laura Dill Morton
Pharmacia Corporation, Skokie, Illinois 60077, laura.dill.morton{at}pharmacia.com
Ashraf F. Youssef
Pharmacia Corporation, Skokie, Illinois 60077
Eric Lloyd
Pharmacia Corporation, Skokie, Illinois 60077
Anthony L. Kiorpes
Primedica Redfield, Redfield, Arkansas 72132
Thomas L. Goldsworthy
Integrated Laboratory Systems, Inc, Research Triangle Park, North Carolina 27709
Farrel L. Fort
Pharmacia Corporation, Skokie, Illinois 60077
This study examined the response of the Eker rat to nephrotoxic compounds and to genotoxic nonrenal carcinogens. Groups of male Eker rats received either no treatment; a vehicle treatment; treatment with a noncarcinogeni c nephrotoxin (aluminum nitrilotriacetate, 2 mg/kg/day of aluminum, intraperitoneally, 3 days per week or cyclosporine A, 30 mg/kg/day, orally by gavage, 7 days/week); or treatment with a genotoxic nonrenal carcinogen (furan, 8 mg/kg/day, orally by gavage, 5 days/week or 2,4-diaminotoluene, 6.5 mg/kg/day, orally by gavage, 7 days/week or 2-nitropropane, 89 mg/kg/day, orally by gavage, 3 days/week). Duration of treatment was 4 and/or 6 months. Tissues from the Eker rats were evaluated microscopically and numbers of proliferative renal lesions were counted. Administration of nephrotoxic compounds (Al-NTA and cyclosporine) significantly increased the number of preneoplasti c and neoplasti c renal lesions in the Eker rat compared to concurrent vehicle controls. The genotoxi c nonrenal carcinogens had no consistent effect on numbers of preneoplastic or neoplastic renal lesions and did not produce neoplasms in the expected target organ (liver).
Key Words: Eker • carcinogenesis • alternative model • rat • bioassay.
References
- Crino PB, Henske EP (1999). New development s in the neurobiology of the tuberous sclerosis complex. Neurology 53: 1384—1390.[Abstract/Free Full Text]
- European Chromosome 16 Tuberous Sclerosis Consortium (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305—1315.[Web of Science][Medline]
[Order article via Infotrieve]
- Everitt JI, Goldsworthy TL, Wolf DC, Walker CL (1992). Hereditary renal cell carcinoma in the Eker model: A rodent cancer syndrome with similarities to von-Hippel-Lindau disease. J Urol 148: 1932—1936.[Web of Science][Medline]
[Order article via Infotrieve]
- Everitt JI, Goldsworthy TL, Wolf DC, Walker CL (1995). Hereditary renal carcinoma in the Eker rat: A unique animal model for the study of cancer susceptibility. Toxicol Lett 82/83: 621—625.[CrossRef]
- Green AJ, Smith M., Yates JRW (1994). Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Gen 6: 193—196.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hino O., Klein-Szanto AJP, Freed JJ, Testa JR, Brown DQ, Vilensky M., Yeung RS, Tartof KD, Knudson AG (1993). Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci USA 90: 327—331.[Abstract/Free Full Text]
- Hino O., Kobayashi T., Mitani H., Kobayashi E., Kubo Y., Tsuchiya H., Kekuchi Y., Nishizawa M., Hirayama Y. (1995). The Eker rat, a model of dominantly inherited cancer syndrome. Transplant Proc 27: 1529—1531.[Web of Science][Medline]
[Order article via Infotrieve]
- Hino O., Kobayashi T., Tsuchiya H., Kikuchi Y., Kobayashi E., Mitani H., Hirayama Y. (1994). The predisposing gene of the Eker rat inherited cancer syndrome is tightly linked to the tuberous sclerosis (Tsc2) gene. Biochem Biophys Res Comm 203: 1302—1308.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hino O., Mitani H., Knudson AG (1993). Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat. Cancer Res 53: 5856—5858.[Abstract/Free Full Text]
- International Conference on Harmonisation (1998). Guidance on testing for carcinogenicity of pharmaceuticals. Fed Regist 63: 8963—8986.
- Kobayashi T., Urakami S., Hirayama Y., Yamamoto T., Nishizawa M., Takahara T., Kubo Y., Hino O. (1997). Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model. Jpn J Cancer Res 88: 254—261.[CrossRef][Web of Science]
- Kubo Y., Kikuchi Y., Mitani H., Kobayashi E., Kobayashi T., Hino O. ( 1995). Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneou s uterine leiomyosarcoma s and pituitary adenoma s in the Eker rat model. Jpn J Canc Res 86: 828—832.
- Lau SS, Monks TJ, Everitt JI, Kleymenova E., Walker CW (2001). Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone. Chem Res Toxicol 14: 25—33.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Maronpot RR, Giles HD, Dykes DJ, Irwin RD (1991). Furan-induced hepatic cholangiocarcinomas in Fischer 344 rats. Toxicol Pathol 19: 561—569.[Web of Science][Medline]
[Order article via Infotrieve]
- Nellist M., van Slegtenhorst MA, Goedbloed M., van den Ouweland MW, Halley DJJ, van der Sluijs P. (1999). Characterization of the cytosolic tuberin-hamartin complex. J Biol Chem 50: 35647—35652.
- Tennant RW, Spalding J., French JE (1996). Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutation Res 365: 119—127.[Medline]
[Order article via Infotrieve]
- Van Slegtenhorst MA, de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., Lindhout D., van den Ouweland A., Halley D., Young J., Burley M., Jeremiah S., Woodward K., Nahmias J., Fox M., Ekong R., Osborne J., Wolfe J., Povey S., Snell RG, Cheadle JP, Jones AC, Tachataki M., Ravine D., Sampson JR, Reeve MP, Richardson P., Wilmer F., Munro C., Hawkins TL, Sepp T., Ali JBM, Ward S., Green AJ, Yates JRW, Kwiatkowska J., Henske EP, Short MP, Haines JH, Jozwiak S., Kwiatkowski DJ (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805—808.[Abstract/Free Full Text]
- Walker CL, Goldsworthy TL, Wolf DC, Everitt JI (1992). Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science 255: 1693—1695.[Abstract/Free Full Text]
- Wolf DC, Goldsworthy TL, Donner EM, Harden R., Fitzpatrick B., Everitt JI (1998). Estrogen treatment enhances hereditary renal tumor development in Eker rats. Carcinogenesis 19: 2043—2947.[Abstract/Free Full Text]
- Xiao G-H., Yeung RS (1995) Germ-line Tsc2 mutation in a dominantly inherited cancer model defines a novel family of rat intracisternal-A particle elements. Oncogene 11: 81—87.[Web of Science][Medline]
[Order article via Infotrieve]
- Yeung RS, Guang-Hui X., Everitt JI, Jin F., Walker CL (1995). Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol Carcinogen 14: 28—36.[Web of Science][Medline]
[Order article via Infotrieve]
- Yeung RS, Guang-Hui X., Jin F., Lee W-C., Testa JR, Knudson AG (1994). Predisposition for renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 91: 11413—11416.[Abstract/Free Full Text]
- Yeung RS, Katsetos CD, Klein-Szanto A. (1997). Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol 151: 1477—1486.[Abstract]
Toxicologic Pathology, Vol. 30, No. 5,
559-564 (2002)
DOI: 10.1080/01926230290105794
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
K. Stemmer, H. Ellinger-Ziegelbauer, H.-J. Ahr, and D. R. Dietrich
Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors
Am. J. Pathol.,
October 1, 2009;
175(4):
1686 - 1698.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
